| Tijdsbestek | Voorspelde prijs | Verleden | Historisch | Inzicht |
|---|---|---|---|---|
| Morgen | $20.95 ▲ +1.33% | Gisteren | $20.56 ▼ -0.56% | Tomorrow's Sarepta Therapeutics Inc. Common Stock (DE) (SRPT) setup is anchored to $20.68 and targets $20.95 (+1.33%). The near-term read is upside; watch $21.30 / $20.06 because daily realized volatility is about 6.84%. |
Tomorrow's Sarepta Therapeutics Inc. Common Stock (DE) (SRPT) setup is anchored to $20.68 and targets $20.95 (+1.33%). The near-term read is upside; watch $21.30 / $20.06 because daily realized volatility is about 6.84%. | ||||
| Week | $21.53 ▲ +4.12% | Vorige week | $20.32 ▼ -1.73% | The 7-day Sarepta Therapeutics Inc. Common Stock (DE) model moves from $20.32 to $21.53 (+4.12%). It gives upside momentum context for this stock, so breaks around $21.30 / $20.06 matter more than a single tick. |
The 7-day Sarepta Therapeutics Inc. Common Stock (DE) model moves from $20.32 to $21.53 (+4.12%). It gives upside momentum context for this stock, so breaks around $21.30 / $20.06 matter more than a single tick. | ||||
| Maand | $22.50 ▲ +8.79% | Vorige maand | $19.92 ▼ -3.69% | The 1-month Sarepta Therapeutics Inc. Common Stock (DE) target is $22.50 (+8.79%), compared with the live reference near $20.68. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Sarepta Therapeutics Inc. Common Stock (DE) target is $22.50 (+8.79%), compared with the live reference near $20.68. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Jaar | $23.94 ▲ +15.77% | Vorig jaar | $19.31 ▼ -6.62% | The 1-year Sarepta Therapeutics Inc. Common Stock (DE) scenario points to $23.94 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Sarepta Therapeutics Inc. Common Stock (DE) scenario points to $23.94 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 jaar | $27.33 ▲ +32.14% | 5 jaar geleden | $17.89 ▼ -13.50% | The 5-year Sarepta Therapeutics Inc. Common Stock (DE) view is $27.33 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Sarepta Therapeutics Inc. Common Stock (DE) view is $27.33 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Waarde | Signaal |
|---|---|---|
| Price | $20.68 | Mid |
| Daily Change | -3.46% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $20.68 | Daily Change | -3.46% |
| Market Cap | $2.17B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.